Psomagen and Macrogen Granted U.S. Patent for Blockchain Data-sharing Technology
(WorldNews Business)

SEOUL, South Korea--(BUSINESS WIRE)--Sep 17, 2019-- The precision medicine and biotechnology company Macrogen (CEO Kap-Seok Yang, www.macrogen.com ) announced on September 17 that it had been granted a U.S. patent for its blockchain-based data-sharing technology. The patent for a `data-sharing method based on the plurality of blockchains (patent No. 10417219)´ was jointly filed with the USPTO (United States Patent and Trademark Office) by Psomagen and Macrogen. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190917005461/en/ The precision medicine and biotechnology company Macrogen (CEO Kap-Seok Yang, www.macrogen.com) announced on...